Multifactorial treatment for improvement of renal function and cardiovascular risk: an ATTEMPT for patients with metabolic syndrome and chronic kidney disease

Author： Katsiki Niki   Elisaf Moses  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.27, Iss.8, 2011-08, pp. : 1669-1672

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Statins in patients with chronic kidney disease – an attempt at recommendations

By Banach Maciej    

Current Medical Research and Opinion, Vol. 29, Iss. 11, 2013-11 ,pp. : 1419-1422

Informa Healthcare

Access to resources Recommend Favorite

Treatment of Anaemia with Erythropoiesis-Stimulating Agents in Patients with Chronic Kidney Disease Does Not Lower Mortality and May Increase Cardiovascular Risk: A Meta-Analysis

By  

Nephron Clin Pract, Vol. 121, Iss. 3-4, 2012-11 ,pp. : c95-c101

Karger

Access to resources Recommend Favorite

Chronic kidney disease and bleeding risk in patients at high cardiovascular risk: a cohort study

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 16, Iss. 1, 2018-01 ,pp. : 65-73

John Wiley & Sons Inc

Access to resources Recommend Favorite

Patients with medical risk factors for chronic kidney disease are at increased risk of renal impairment despite the use of nephron‐sparing surgery

By  

BJU INTERNATIONAL, Vol. 116, Iss. 4, 2015-10 ,pp. : 590-595

John Wiley & Sons Inc

Access to resources Recommend Favorite

Intravenous Iron Therapy and Risk for Progressive Loss of Kidney Function in Patients with Chronic Kidney Disease

By  

Nephron Clin Pract, Vol. 118, Iss. 2, 2010-12 ,pp. : c189-c194

Karger

Access to resources Recommend Favorite